First Time Loading...

Ekso Bionics Holdings Inc
NASDAQ:EKSO

Watchlist Manager
Ekso Bionics Holdings Inc Logo
Ekso Bionics Holdings Inc
NASDAQ:EKSO
Watchlist
Price: 1.25 USD -2.34% Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

EKSO Price Targets Summary
Ekso Bionics Holdings Inc

There are no price targets for EKSO.
EKSO Lowest Forecast
Wall Street Target
Not Available
EKSO Average Forecast
Wall Street Target
Not Available
EKSO Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available

EKSO Last Price Targets
Ekso Bionics Holdings Inc

The latest public price target was made on Jul 29, 2022 by Unknown Analyst from H.C. Wainwright , who expects EKSO stock to rise by 620% over the next 12 months. You can read more about this price target by viewing the article on Benzinga.

Analyst Price Target Date Article
Unknown Analyst
H.C. Wainwright
9 USD
Upside 620%
1 year ago
Jul 29, 2022
HC Wainwright & Co. Maintains Buy on Ekso Bionics Holdings, Lowers Price Target to $9
Benzinga
Unknown Analyst
H.C. Wainwright
Price Target 9 USD
Upside/Downside 620%
View Source
Ekso Bionics Holdings Inc Competitors:
Price Targets
TFX
Teleflex Inc
31% Upside
300562
Guangdong Transtek Medical Electronics Co Ltd
58% Upside
EKF
EKF Diagnostics Holdings PLC
15% Upside
SBS
Stratec SE
21% Upside
TFX
Teleflex Inc
31% Upside
300562
Guangdong Transtek Medical Electronics Co Ltd
58% Upside
EKF
EKF Diagnostics Holdings PLC
15% Upside
SBS
Stratec SE
21% Upside
ENOV
Enovis Corp
39% Upside
ALCOR
Biocorp Production SA
1% Upside
GETI B
Getinge AB
11% Upside
CODX
Co-Diagnostics Inc
130% Upside

Revenue
Forecast

Revenue Estimate
Ekso Bionics Holdings Inc

For the last 8 years the compound annual growth rate for Ekso Bionics Holdings Inc's revenue is 10%. The projected CAGR for the next 3 years is 30%.

10%
Past Growth
30%
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Ekso Bionics Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Ekso Bionics Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-78%
Average Miss
What are analyst estimates?

See Also

Summary
EKSO intrinsic value, competitors valuation, and company profile.
DCF Valuation
EKSO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EKSO stock valuation using valuation multiples.
Wall Street Estimates
EKSO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EKSO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EKSO's stock price target?
Not Available

EKSO doesn't have any price targets made by Wall Street professionals.

What is Ekso Bionics Holdings Inc's Revenue forecast?
Projected CAGR
30%

For the last 8 years the compound annual growth rate for Ekso Bionics Holdings Inc's revenue is 10%. The projected CAGR for the next 3 years is 30%.

ALPHA SPREAD
Join more than 132,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.